1206 related articles for article (PubMed ID: 24080150)
1. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
2. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
5. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
6. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
Pendergraft T; Liu X; Edelsberg J; Phatak H; Vera-Llonch M; Liu LZ; Oster G
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):75-82. PubMed ID: 23300270
[TBL] [Abstract][Full Text] [Related]
9. Hospital-acquired venous thromboembolism and prophylaxis in an integrated hospital delivery system.
Dorfman M; Chan SB; Maslowski C
J Clin Pharm Ther; 2006 Oct; 31(5):455-9. PubMed ID: 16958823
[TBL] [Abstract][Full Text] [Related]
10. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism prophylaxis and clinical consequences in medically ill patients.
Baser O; Liu X; Phatak H; Wang L; Mardekian J; Kawabata H; Petersel D; Hamilton M; Ramacciotti E
Am J Ther; 2013; 20(2):132-42. PubMed ID: 23466619
[TBL] [Abstract][Full Text] [Related]
12. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.
Lim W; Meade M; Lauzier F; Zarychanski R; Mehta S; Lamontagne F; Dodek P; McIntyre L; Hall R; Heels-Ansdell D; Fowler R; Pai M; Guyatt G; Crowther MA; Warkentin TE; Devereaux PJ; Walter SD; Muscedere J; Herridge M; Turgeon AF; Geerts W; Finfer S; Jacka M; Berwanger O; Ostermann M; Qushmaq I; Friedrich JO; Cook DJ;
Crit Care Med; 2015 Feb; 43(2):401-10. PubMed ID: 25474533
[TBL] [Abstract][Full Text] [Related]
13. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
[TBL] [Abstract][Full Text] [Related]
14. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
[TBL] [Abstract][Full Text] [Related]
15. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
[TBL] [Abstract][Full Text] [Related]
16. Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection.
Davenport DL; Vargas HD; Kasten MW; Xenos ES
Clin Appl Thromb Hemost; 2012 Nov; 18(6):569-75. PubMed ID: 22345485
[TBL] [Abstract][Full Text] [Related]
17. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
Salami A; Qureshi W; Kuriakose P; Moonka D; Yoshida A; Abouljoud M
Transplant Proc; 2013; 45(1):315-9. PubMed ID: 23267811
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of physician alerts for thromboprophylaxis after discharge.
Piazza G; Anderson FA; Ortel TL; Cox MJ; Rosenberg DJ; Rahimian S; Pendergast WJ; McLaren GD; Welker JA; Akus JJ; Stevens SM; Elliott CG; Freeman AL; Patton WF; Dabbagh O; Wyman A; Huang W; Rao AF; Goldhaber SZ
Am J Med; 2013 May; 126(5):435-42. PubMed ID: 23510945
[TBL] [Abstract][Full Text] [Related]
19. All-cause mortality and use of antithrombotics within 90 days of discharge in acutely ill medical patients.
Mahan CE; Fields LE; Mills RM; Stephenson JJ; Fu AC; Fisher MD; Spyropoulos AC
Thromb Haemost; 2015 Oct; 114(4):685-94. PubMed ID: 26202514
[TBL] [Abstract][Full Text] [Related]
20. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
